Tag: COVID-19
What are Alabama’s Covid Models?
As national media continue to report criticisms of state policies on reduced lockdowns of the economy, Alabama has become one of the frequent targets.
Recently...
Birmingham Lab One of Two in Nation to Test COVID-19 At-Home Samples
Assurance Scientific Laboratories has been approved by the Food and Drug Administration as one of two laboratories to test specimens for Everlywell COVID-19 at-home...
Alabama Moving to Covid Contact Tracing
Contact tracing of individuals in Alabama infected with SARS-CoV-2 is coming soon, by way of a smart phone application now being developed by the...
New Study: 42% of Covid Deaths in Nursing Homes, Assisted Living Facilities
According to a new analysis of data collected state-by-state from long-term care facilities, nursing homes and assisted living facilities account for 42 percent of...
Jones Says His Bill Will Give Factories New Life
Just last month, three Alabama plants announced plans to close — Goodyear in Gadsden and Honeywell and Monarch Windows and Doors, both in Anniston.
All...
Alabama Hospitals Down $739 Million, Virus Deficit
Alabama hospitals have lost about $739 million in revenue during the virus crisis, the head of the Alabama Hospital Association told the Anniston Star...
WHO Suspends HCQ Trials
The World Health Organization has temporarily suspended a clinical trial of antimalarial drugs for Covid treatment following the May 22 publication by The Lancet...
Bank Independent Sews Masks for Hospitals
Over the last few weeks, Bank Independent team members have sewn and distributed more than 1,000 masks to hospitals across North Alabama to augment...
Post-Covid, Foreign Investment Rules Tighten
Owners and investors need to know —
expansion of regulations
gaps closed in national security reviews
new inclusion of medical supplies and food
non-controlling...
Trump’s Covid Drug, Genetics and Risks
The anti-malaria drug that is being touted by President Donald Trump as a Covid treatment has associated risks, including a genetic-based risk for people...